Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$891M |
| 2 |
Union Pacific
UNP
|
+$622M |
| 3 |
Salesforce
CRM
|
+$418M |
| 4 |
Edwards Lifesciences
EW
|
+$405M |
| 5 |
lululemon athletica
LULU
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$680M |
| 2 |
Texas Instruments
TXN
|
+$585M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$571M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$558M |
| 5 |
Parker-Hannifin
PH
|
+$556M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.29% |
| 2 | Healthcare | 17.78% |
| 3 | Consumer Discretionary | 17.1% |
| 4 | Financials | 12.69% |
| 5 | Communication Services | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$12.5B
| $988M | 1.11% |
11,600,460
+756,222
| +7% | +$71.9M |
|
27
NVIDIA
NVDA
$5.25T
| $948M | 1.06% |
284,181,960
-61,840,320
| -18% | -$296M |
|
28
Intuitive Surgical
ISRG
$132B
| $934M | 1.04% |
5,849,052
+1,687,323
| +41% | +$286M |
|
29
Estee Lauder
EL
$37.4B
| $908M | 1.02% |
6,977,245
-1,221,326
| -15% | -$166M |
|
30
PayPal
PYPL
$45.9B
| $885M | 0.99% |
10,520,228
-3,053,598
| -22% | -$254M |
|
|
ALXN
31
DELISTED
Alexion Pharmaceuticals
ALXN
| $850M | 0.95% |
8,728,912
+101,376
| +1% | +$12M |
|
32
Broadcom
AVGO
$1.75T
| $837M | 0.94% |
32,910,700
+37,220
| +0.1% | +$878K |
|
33
McDonald's
MCD
$188B
| $791M | 0.88% |
4,452,089
+144,372
| +3% | +$25.6M |
|
34
Goldman Sachs
GS
$301B
| $787M | 0.88% |
4,710,738
+710,479
| +18% | +$143M |
|
|
RHT
35
DELISTED
Red Hat Inc
RHT
| $775M | 0.87% |
4,414,198
-3,600,249
| -45% | -$571M |
|
36
Corpay
CPAY
$26.8B
| $751M | 0.84% |
4,043,783
-386,582
| -9% | -$75.6M |
|
37
S&P Global
SPGI
$131B
| $716M | 0.8% |
4,214,877
+1,159,521
| +38% | +$208M |
|
|
38
Union Pacific
UNP
$183B
| $710M | 0.79% |
5,134,698
+4,201,086
| +450% | +$622M |
|
|
SPLK
39
DELISTED
Splunk Inc
SPLK
| $705M | 0.79% |
6,721,710
-249,582
| -4% | -$25.2M |
|
|
ATVI
40
DELISTED
Activision Blizzard
ATVI
| $658M | 0.74% |
14,133,473
-574,472
| -4% | -$34.4M |
|
|
41
Edwards Lifesciences
EW
$52B
| $630M | 0.7% |
12,336,399
+8,003,247
| +185% | +$405M |
|
|
42
Bristol-Myers Squibb
BMY
$136B
| $579M | 0.65% |
11,140,493
-10,386,066
| -48% | -$558M |
|
43
Booking.com
BKNG
$155B
| $559M | 0.63% |
8,109,900
-1,835,050
| -18% | -$135M |
|
|
XYZ
44
Block Inc
XYZ
$50.2B
| $542M | 0.61% |
9,663,722
+2,470,434
| +34% | +$174M |
|
45
Albemarle
ALB
$16.2B
| $536M | 0.6% |
6,954,209
-941,892
| -12% | -$88.9M |
|
46
Crown Castle
CCI
$32.4B
| $497M | 0.56% |
4,571,756
+2,400,421
| +111% | +$264M |
|
47
American Tower
AMT
$82.1B
| $456M | 0.51% |
2,881,240
+1,932,136
| +204% | +$302M |
|
48
ServiceNow
NOW
$150B
| $428M | 0.48% |
12,030,385
+8,881,900
| +282% | +$315M |
|
49
Eli Lilly
LLY
$1.05T
| $396M | 0.44% |
3,425,424
+1,280,878
| +60% | +$143M |
|
|
CELG
50
DELISTED
Celgene Corp
CELG
| $381M | 0.43% |
5,938,788
-2,289,336
| -28% | -$169M |
|
Similar funds
Jennison Associates's Q4 2018 Portfolio in Review
As of Q4 2018, Jennison Associates held 753 positions worth $89.4B, down 18% from $109B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q4 2018 filing shows 95 new, 255 increased, 283 reduced and 113 closed positions. Its largest new stake was lululemon athletica: 2,588,881 shares worth $315M. The largest sale was Caterpillar, an estimated $680M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jennison Associates's largest Q4 2018 buy was lululemon athletica: 2,588,881 shares worth $315M.
- Jennison Associates added most to Merck in Q4 2018, an estimated $891M increase.
- Jennison Associates's biggest Q4 2018 reduction was Caterpillar, cutting an estimated $680M.
- Jennison Associates fully exited Tiffany & Co. in Q4 2018, selling an estimated $151M.
- Jennison Associates's ten largest holdings make up 30% of its $89.4B portfolio in Q4 2018.
- Jennison Associates opened 95 new positions and closed 113 in Q4 2018.
- Jennison Associates's portfolio value fell 18% quarter-over-quarter to $89.4B.
Based on Jennison Associates's 13F filing for Q4 2018, filed 6 Feb 2019.